Skip to content

Current ratio at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
3.6×-1.4×
Opko Health logo
Opko HealthOPK
3.6×+1.1×
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
22.1×+2.2×
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
4.9×+1.9×
ALN
Alnylam PharmaceuticalsALNY
3.1×+0.1×
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
6.1×+1.2×

Other financials

Income statement

See full
Revenue$293.0K-84.8%
Operating income-$40.8M+1.9%
Net income-$46.3M-15.8%
EPS (diluted)-$0.57-11.8%

Balance sheet

See full
Cash & equivalents$71.5M+7.5%
Total debt$62.7M-22.5%
Total equity-$58.1M-276%
Total assets$244.7M+9.2%

Cash flow

See full
Operating cash flow$17.8M+148%
CapEx$2.0M+17.4%
Free cash flow$15.8M+141%

Valuation

See full
Market cap$1.07B+111%
Enterprise value$1.07B+103%
P/S13.5×-1.3×

Profitability

See full
Operating margin-597.9%-207pp
Net margin-615.3%
FCF margin-441.5%-126pp

Returns & leverage

See full
Return on equity-379.5%
Debt / equity27.2×+26.1×

Where this comes from

Calculated from MeiraGTx Holdings plc’s reported figures.

Based on the most recent quarter.

The official record: MeiraGTx Holdings plc’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MeiraGTx Holdings plc's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MeiraGTx Holdings plc's current ratio?
MeiraGTx Holdings plc (MGTX) reported current ratio of 0.5× in Q1 2026.
How has MeiraGTx Holdings plc's current ratio changed year-over-year?
MeiraGTx Holdings plc's current ratio decreased by 64.2% year-over-year, from 1.5× to 0.5×.
What is the long-term trend for MeiraGTx Holdings plc's current ratio?
Over 5 years (2020 to 2025), MeiraGTx Holdings plc's current ratio has grown at a -31.7% compound annual growth rate (CAGR), from 5× to 0.7×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.